Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy

Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy

<p>Abstract</p> <p>Background</p> <p>Breast cancer stem cells (BCSCs) are the source of breast tumors. Compared with other cancer cells, cancer stem cells show high resistance to both chemotherapy and radiotherapy. Targeting of BCSCs is thus a potentially promising and...

Full description

Bibliographic Details
Main Authors: Pham Phuc V, Phan Nhan LC, Nguyen Nhung T, Truong Nhung H, Duong Thuy T, Le Dong V, Truong Kiet D, Phan Ngoc K
Format: Article
Language:English
Published: BMC 2011-12-01
Series:Journal of Translational Medicine
Subjects:
Breast cancer stem cells
Breast cancer cells
CD44
Differentiation
Differentiation therapy
Knockdown
Online Access:http://www.translational-medicine.com/content/9/1/209

Internet

http://www.translational-medicine.com/content/9/1/209

Similar Items